| Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway J Son, CA Lyssiotis, H Ying, X Wang, S Hua, M Ligorio, RM Perera, ... Nature 496 (7443), 101-105, 2013 | 2002 | 2013 |
| Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 1478 | 2017 |
| Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ... Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017 | 1057 | 2017 |
| BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ... Clinical cancer research 19 (5), 1225-1231, 2013 | 1007 | 2013 |
| Clinicopathologic correlates of solitary fibrous tumors JS Gold, CR Antonescu, C Hajdu, CR Ferrone, M Hussain, JJ Lewis, ... Cancer 94 (4), 1057-1068, 2002 | 938 | 2002 |
| Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ... Annals of surgery 261 (1), 12-17, 2015 | 895 | 2015 |
| Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors T Stylianopoulos, JD Martin, VP Chauhan, SR Jain, B Diop-Frimpong, ... Proceedings of the National Academy of Sciences 109 (38), 15101-15108, 2012 | 890 | 2012 |
| Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology MA Tempero, MP Malafa, M Al-Hawary, SW Behrman, AB Benson, ... Journal of the National Comprehensive Cancer Network 19 (4), 439-457, 2021 | 880 | 2021 |
| Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function A Boni, AP Cogdill, P Dang, D Udayakumar, CNJ Njauw, CM Sloss, ... Cancer research 70 (13), 5213-5219, 2010 | 810 | 2010 |
| Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism RM Perera, S Stoykova, BN Nicolay, KN Ross, J Fitamant, M Boukhali, ... Nature 524 (7565), 361-365, 2015 | 802 | 2015 |
| High-fat diet enhances stemness and tumorigenicity of intestinal progenitors S Beyaz, MD Mana, J Roper, D Kedrin, A Saadatpour, SJ Hong, ... Nature 531 (7592), 53-58, 2016 | 799 | 2016 |
| Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment MC De Jong, H Nathan, GC Sotiropoulos, A Paul, S Alexandrescu, ... Journal of Clinical Oncology 29 (23), 3140-3145, 2011 | 770 | 2011 |
| Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma CR Ferrone, DM Finkelstein, SP Thayer, A Muzikansky, CF Castillo, ... Journal of clinical oncology 24 (18), 2897-2902, 2006 | 623 | 2006 |
| Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial JE Murphy, JY Wo, DP Ryan, W Jiang, BY Yeap, LC Drapek, ... JAMA oncology 4 (7), 963-969, 2018 | 571 | 2018 |
| Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells DT Ting, BS Wittner, M Ligorio, NV Jordan, AM Shah, DT Miyamoto, ... Cell reports 8 (6), 1905-1918, 2014 | 531 | 2014 |
| Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ... Annals of surgery 265 (1), 185-191, 2017 | 507 | 2017 |
| Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer SK Saha, CA Parachoniak, KS Ghanta, J Fitamant, KN Ross, MS Najem, ... Nature 513 (7516), 110-114, 2014 | 491 | 2014 |
| 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital NP Valsangkar, V Morales-Oyarvide, SP Thayer, CR Ferrone, JA Wargo, ... Surgery 152 (3), S4-S12, 2012 | 491 | 2012 |
| Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection? IT Konstantinidis, AL Warshaw, JN Allen, LS Blaszkowsky, ... Annals of surgery 257 (4), 731-736, 2013 | 489 | 2013 |
| Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype S Ogino, K Nosho, N Irahara, JA Meyerhardt, Y Baba, K Shima, ... Clinical Cancer Research 15 (20), 6412-6420, 2009 | 482 | 2009 |
